{"transactions":[{"id":691804,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-10T21:30:12.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":49995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Such aggregate number reflects the remainder of such RSUs granted on August 6, 2025, but does not include any other RSUs held by such Reporting Person."}],"balance_after":100005,"derivative":{"underlying":"Common Stock","underlying_shares":49995},"source":{"system":"sec-edgar","filing":"0001104659-26-093482","document":"tm2622610-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926093482/tm2622610-1_4seq1.xml","form_type":"4"}},{"id":691803,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-10T21:30:12.000Z","date":"2026-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":21238,"price":6.21,"value":131887.98,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":28757,"source":{"system":"sec-edgar","filing":"0001104659-26-093482","document":"tm2622610-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926093482/tm2622610-1_4seq1.xml","form_type":"4"}},{"id":691802,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-10T21:30:12.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":49995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."}],"balance_after":49995,"source":{"system":"sec-edgar","filing":"0001104659-26-093482","document":"tm2622610-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926093482/tm2622610-1_4seq1.xml","form_type":"4"}},{"id":848564,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:25:27.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":132200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":132200,"derivative":{"underlying":"Common stock","underlying_shares":132200},"source":{"system":"sec-edgar","filing":"0001104659-26-026475","document":"tm268453-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926026475/tm268453-5_4seq1.xml","form_type":"4"}},{"id":1071285,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-08T20:06:19.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":150000,"derivative":{"underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-075687","document":"tm2522878-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925075687/tm2522878-2_4seq1.xml","form_type":"4"}},{"id":1071284,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-08T20:06:19.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":300000,"derivative":{"exercise_price":2.58,"expiration_date":"2035-08-06","underlying":"Common stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-25-075687","document":"tm2522878-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925075687/tm2522878-2_4seq1.xml","form_type":"4"}},{"id":1170744,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-16T20:15:09.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":143907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date."}],"balance_after":143907,"derivative":{"exercise_price":20.11,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":143907},"source":{"system":"sec-edgar","filing":"0000950170-25-054737","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857905/000095017025054737/ownership.xml","form_type":"4"}},{"id":1388984,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-08T13:29:44.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":93600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":93600,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":93600},"source":{"system":"sec-edgar","filing":"0000950170-24-113418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857905/000095017024113418/ownership.xml","form_type":"4"}},{"id":1664760,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2024-01-31T21:30:20.000Z","date":"2024-01-29","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":19,"value":38000.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000950170-24-009432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857905/000095017024009432/ownership.xml","form_type":"4"}},{"id":1669161,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Stock Option","published_at":"2024-01-26T21:30:07.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":492920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the underlying shares on January 16, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter."}],"balance_after":492920,"derivative":{"exercise_price":19,"expiration_date":"2034-01-10","underlying":"Common Stock","underlying_shares":492920},"source":{"system":"sec-edgar","filing":"0000950170-24-007962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857905/000095017024007962/ownership.xml","form_type":"4"}},{"id":1858696,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:58:46.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":58000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-forty-eighth (1/48th) of the shares subject to such options shall vest monthly over forty-eight months after the grant date."}],"balance_after":58000,"derivative":{"exercise_price":4.84,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":58000},"source":{"system":"sec-edgar","filing":"0001104659-23-070411","document":"tm2318426-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923070411/tm2318426-10_4seq1.xml","form_type":"4"}},{"id":2225340,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:06:53.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"With respect to the options to purchase 40,000 shares, 25% of the shares subject to such options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to such options shall vest every month thereafter. With respect to the remaining options to purchase 30,000 shares, 50% of the shares subject to such options vest on June 16, 2023, and the remaining 50% of the shares subject to such options vest on June 16, 2024."}],"balance_after":70000,"derivative":{"exercise_price":3.42,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-22-073103","document":"tm2218674-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465922073103/tm2218674-9_4seq1.xml","form_type":"4"}},{"id":2688869,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T23:21:54.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":16609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter."}],"balance_after":16609,"derivative":{"exercise_price":20.92,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":16609},"source":{"system":"sec-edgar","filing":"0001104659-21-075235","document":"tm2118079-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921075235/tm2118079-6_4seq1.xml","form_type":"4"}},{"id":2743007,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24984,"kind":"person","name":"Roche Corleen M.","position":1,"cik":"0001857905","reported_name":"Roche Corleen M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T01:38:59.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on April 19, 2022, and the remaining 75% of shares subject to the option shall vest in equal monthly installments for the 36\nmonths thereafter."}],"balance_after":125000,"derivative":{"exercise_price":27.53,"expiration_date":"2031-04-19","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-21-053339","document":"tm2113705-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921053339/tm2113705-2_4seq1.xml","form_type":"4"}}]}